Pain:共生菌通过调节宿主的免疫反应改善慢性前列腺炎疼痛。

2017-07-22 fengxiangxin MedSci原创

共生菌在调控人类免疫平衡中扮演重要的角色。表皮葡萄球菌,一种与皮肤紧密联系的共生菌,在炎症以及预防病原体(如,金黄色酿脓葡萄球菌) 重叠感染中发挥着局部免疫平衡调控作用。

共生菌在调控人类免疫平衡中扮演重要的角色。表皮葡萄球菌,一种与皮肤紧密联系的共生菌,在炎症以及预防病原体(如,金黄色酿脓葡萄球菌) 重叠感染中发挥着局部免疫平衡调控作用。

尽管以往前列腺被认为是无菌的,但多个研究表明能够从健康和患病男性的前列腺分泌物中分离出少量的革兰氏阳性细菌,如表皮葡萄球菌。慢性盆腔疼痛综合征是一种病因未知主要表现为盆腔疼痛和下尿路功能障碍的复杂综合征,现有的治疗疗效也较为有限,但其与前列腺免疫反应的调节相关。慢性盆腔疼痛综合征可以用小鼠实验性前列腺炎(EAP)建立模型,在该模型中CD4 + ve IL17A + veT细胞已被证明在疾病控制和改善盆腔触痛觉超敏中起着至关重要的作用。

研究者将从健康男性前列腺液中分离出一种具体的表皮葡萄球菌菌株(命名为NPI [非疼痛诱导菌株])通过尿道灌注入EAP小鼠之后,减轻了盆腔触痛觉异常超敏反应,以及增加了与EAP相关的CD4+ve IL17A+ve T细胞数量。此外,从NPI的细胞壁中分离出的脂膜酸,通过增加CTLA4样配体PDL1PDL2在前列腺 CD11b+ve抗原提呈细胞中的表达加明确了这些影响和调节作用。

这些结果确定了非疼痛诱导共生表皮葡萄球菌在前列腺炎相关疼痛治疗中的潜在作用。

原始出处:

Murphy, S.F., A.J. Schaeffer, J.D. Done, et al., Commensal bacterial modulation of the host immune response to ameliorate pain in a murine model of chronic prostatitis. Pain, 2017. 158(8): p. 1517-1527.

本文系梅斯医学(MEDSCI)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=266704, encodeId=9e74266e04a2, content=有更多关于慢前治疗方案和前景的文章吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2RVOmXKf7WhiaSUDoKbZD6Sl7SbQZ96iaicwXtA62Oj0x2gQd2r7yN7icd1VXeC6E72Dc09IKuNJtSiad/0, createdBy=304b2052342, createdName=白雪浪子, createdTime=Mon Dec 04 10:20:52 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944071, encodeId=c71b19440e133, content=<a href='/topic/show?id=02c930028f2' target=_blank style='color:#2F92EE;'>#共生菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30028, encryptionId=02c930028f2, topicName=共生菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Mon Sep 11 16:36:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280166, encodeId=fe8c12801668a, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Mon Jul 24 06:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404679, encodeId=114a14046e9fe, content=<a href='/topic/show?id=1a4f4649925' target=_blank style='color:#2F92EE;'>#宿主#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46499, encryptionId=1a4f4649925, topicName=宿主)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/08904ED76550A0090DB220A7FB81D755/100, createdBy=78512492586, createdName=wincls, createdTime=Mon Jul 24 06:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225287, encodeId=391322528e7e, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jul 23 07:38:58 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225114, encodeId=928f225114aa, content=千丝万缕屡不清啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRr63iayTjay9otQ2yDAmbravgszHBxSLHIJpTZ8uNAiaa87bfqeDpEPTUicdBhBlf5yABuAj1OwClO4/0, createdBy=c3622063904, createdName=fengxiangxin301, createdTime=Sat Jul 22 15:44:50 CST 2017, time=2017-07-22, status=1, ipAttribution=)]
    2017-12-04 白雪浪子

    有更多关于慢前治疗方案和前景的文章吗?

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=266704, encodeId=9e74266e04a2, content=有更多关于慢前治疗方案和前景的文章吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2RVOmXKf7WhiaSUDoKbZD6Sl7SbQZ96iaicwXtA62Oj0x2gQd2r7yN7icd1VXeC6E72Dc09IKuNJtSiad/0, createdBy=304b2052342, createdName=白雪浪子, createdTime=Mon Dec 04 10:20:52 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944071, encodeId=c71b19440e133, content=<a href='/topic/show?id=02c930028f2' target=_blank style='color:#2F92EE;'>#共生菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30028, encryptionId=02c930028f2, topicName=共生菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Mon Sep 11 16:36:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280166, encodeId=fe8c12801668a, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Mon Jul 24 06:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404679, encodeId=114a14046e9fe, content=<a href='/topic/show?id=1a4f4649925' target=_blank style='color:#2F92EE;'>#宿主#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46499, encryptionId=1a4f4649925, topicName=宿主)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/08904ED76550A0090DB220A7FB81D755/100, createdBy=78512492586, createdName=wincls, createdTime=Mon Jul 24 06:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225287, encodeId=391322528e7e, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jul 23 07:38:58 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225114, encodeId=928f225114aa, content=千丝万缕屡不清啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRr63iayTjay9otQ2yDAmbravgszHBxSLHIJpTZ8uNAiaa87bfqeDpEPTUicdBhBlf5yABuAj1OwClO4/0, createdBy=c3622063904, createdName=fengxiangxin301, createdTime=Sat Jul 22 15:44:50 CST 2017, time=2017-07-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=266704, encodeId=9e74266e04a2, content=有更多关于慢前治疗方案和前景的文章吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2RVOmXKf7WhiaSUDoKbZD6Sl7SbQZ96iaicwXtA62Oj0x2gQd2r7yN7icd1VXeC6E72Dc09IKuNJtSiad/0, createdBy=304b2052342, createdName=白雪浪子, createdTime=Mon Dec 04 10:20:52 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944071, encodeId=c71b19440e133, content=<a href='/topic/show?id=02c930028f2' target=_blank style='color:#2F92EE;'>#共生菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30028, encryptionId=02c930028f2, topicName=共生菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Mon Sep 11 16:36:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280166, encodeId=fe8c12801668a, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Mon Jul 24 06:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404679, encodeId=114a14046e9fe, content=<a href='/topic/show?id=1a4f4649925' target=_blank style='color:#2F92EE;'>#宿主#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46499, encryptionId=1a4f4649925, topicName=宿主)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/08904ED76550A0090DB220A7FB81D755/100, createdBy=78512492586, createdName=wincls, createdTime=Mon Jul 24 06:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225287, encodeId=391322528e7e, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jul 23 07:38:58 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225114, encodeId=928f225114aa, content=千丝万缕屡不清啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRr63iayTjay9otQ2yDAmbravgszHBxSLHIJpTZ8uNAiaa87bfqeDpEPTUicdBhBlf5yABuAj1OwClO4/0, createdBy=c3622063904, createdName=fengxiangxin301, createdTime=Sat Jul 22 15:44:50 CST 2017, time=2017-07-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=266704, encodeId=9e74266e04a2, content=有更多关于慢前治疗方案和前景的文章吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2RVOmXKf7WhiaSUDoKbZD6Sl7SbQZ96iaicwXtA62Oj0x2gQd2r7yN7icd1VXeC6E72Dc09IKuNJtSiad/0, createdBy=304b2052342, createdName=白雪浪子, createdTime=Mon Dec 04 10:20:52 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944071, encodeId=c71b19440e133, content=<a href='/topic/show?id=02c930028f2' target=_blank style='color:#2F92EE;'>#共生菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30028, encryptionId=02c930028f2, topicName=共生菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Mon Sep 11 16:36:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280166, encodeId=fe8c12801668a, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Mon Jul 24 06:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404679, encodeId=114a14046e9fe, content=<a href='/topic/show?id=1a4f4649925' target=_blank style='color:#2F92EE;'>#宿主#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46499, encryptionId=1a4f4649925, topicName=宿主)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/08904ED76550A0090DB220A7FB81D755/100, createdBy=78512492586, createdName=wincls, createdTime=Mon Jul 24 06:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225287, encodeId=391322528e7e, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jul 23 07:38:58 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225114, encodeId=928f225114aa, content=千丝万缕屡不清啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRr63iayTjay9otQ2yDAmbravgszHBxSLHIJpTZ8uNAiaa87bfqeDpEPTUicdBhBlf5yABuAj1OwClO4/0, createdBy=c3622063904, createdName=fengxiangxin301, createdTime=Sat Jul 22 15:44:50 CST 2017, time=2017-07-22, status=1, ipAttribution=)]
    2017-07-24 wincls
  5. [GetPortalCommentsPageByObjectIdResponse(id=266704, encodeId=9e74266e04a2, content=有更多关于慢前治疗方案和前景的文章吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2RVOmXKf7WhiaSUDoKbZD6Sl7SbQZ96iaicwXtA62Oj0x2gQd2r7yN7icd1VXeC6E72Dc09IKuNJtSiad/0, createdBy=304b2052342, createdName=白雪浪子, createdTime=Mon Dec 04 10:20:52 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944071, encodeId=c71b19440e133, content=<a href='/topic/show?id=02c930028f2' target=_blank style='color:#2F92EE;'>#共生菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30028, encryptionId=02c930028f2, topicName=共生菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Mon Sep 11 16:36:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280166, encodeId=fe8c12801668a, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Mon Jul 24 06:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404679, encodeId=114a14046e9fe, content=<a href='/topic/show?id=1a4f4649925' target=_blank style='color:#2F92EE;'>#宿主#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46499, encryptionId=1a4f4649925, topicName=宿主)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/08904ED76550A0090DB220A7FB81D755/100, createdBy=78512492586, createdName=wincls, createdTime=Mon Jul 24 06:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225287, encodeId=391322528e7e, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jul 23 07:38:58 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225114, encodeId=928f225114aa, content=千丝万缕屡不清啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRr63iayTjay9otQ2yDAmbravgszHBxSLHIJpTZ8uNAiaa87bfqeDpEPTUicdBhBlf5yABuAj1OwClO4/0, createdBy=c3622063904, createdName=fengxiangxin301, createdTime=Sat Jul 22 15:44:50 CST 2017, time=2017-07-22, status=1, ipAttribution=)]
    2017-07-23 txqjm

    谢谢了,学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=266704, encodeId=9e74266e04a2, content=有更多关于慢前治疗方案和前景的文章吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2RVOmXKf7WhiaSUDoKbZD6Sl7SbQZ96iaicwXtA62Oj0x2gQd2r7yN7icd1VXeC6E72Dc09IKuNJtSiad/0, createdBy=304b2052342, createdName=白雪浪子, createdTime=Mon Dec 04 10:20:52 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944071, encodeId=c71b19440e133, content=<a href='/topic/show?id=02c930028f2' target=_blank style='color:#2F92EE;'>#共生菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30028, encryptionId=02c930028f2, topicName=共生菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Mon Sep 11 16:36:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280166, encodeId=fe8c12801668a, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Mon Jul 24 06:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404679, encodeId=114a14046e9fe, content=<a href='/topic/show?id=1a4f4649925' target=_blank style='color:#2F92EE;'>#宿主#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46499, encryptionId=1a4f4649925, topicName=宿主)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/08904ED76550A0090DB220A7FB81D755/100, createdBy=78512492586, createdName=wincls, createdTime=Mon Jul 24 06:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225287, encodeId=391322528e7e, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jul 23 07:38:58 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225114, encodeId=928f225114aa, content=千丝万缕屡不清啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRr63iayTjay9otQ2yDAmbravgszHBxSLHIJpTZ8uNAiaa87bfqeDpEPTUicdBhBlf5yABuAj1OwClO4/0, createdBy=c3622063904, createdName=fengxiangxin301, createdTime=Sat Jul 22 15:44:50 CST 2017, time=2017-07-22, status=1, ipAttribution=)]
    2017-07-22 fengxiangxin301

    千丝万缕屡不清啊

    0

相关资讯

Sci Rep:类型III前列腺炎男性中,具有临床症状的前列腺钙化与治疗结果关系的前瞻性研究

最近,有研究人员调查了患有慢性前列腺炎男性前列腺钙化的临床意义,并且讨论了可能的治疗方法。研究人员对来自277名患有CP/CPPS的年轻男性数据资料进行了前瞻性的分析,并利用美国国立卫生研究院慢性前列腺炎症状指数(NIH-CPSI)和国际前列腺症状评分(IPSS)对症状严重度进行了测量,还利用了国际阴茎勃起功能指数调查问卷(IIEF-5)对性功能进行了评估。在为期四周的治疗后,研究人员对NIH-C

Dentistry:速来围观,治疗牙龈疾病可以缓解前列腺炎的症状

Science Daily:速来围观,治疗牙龈疾病可以缓解前列腺炎的症状据Science Daily报道,来自克利夫兰市凯斯西储大学的研究表明,治疗牙龈疾病可能有助于减少前列腺炎的症状。此前已有研究发现牙龈疾病和前列腺炎之间据有关联。“这项研究表明,如果我们治疗牙龈疾病,可以改善前列腺炎的症状,提高患者的生活质量。”研究的通讯作者、克利夫兰市凯斯西储大学牙周病学教授Nabil Bissada博士说

[不合适]2017创普健康男科论坛在京举行

“微能量医学这股浪潮势不可挡,它将成为医学中不可或缺的一门学科,特别在男科疾病领域将大有作为。”前不久,在2017创普健康男科论坛开幕式上,中国工程院院士郭应禄表示,微能量医学目前已经应用临床,在慢性前列腺炎、勃起功能障碍等方面,取得了令人惊喜的效果。

精液不液化,再多精子也枉然

当你的精液报告单上出现“不液化“三个字,意味着什么?有的人这次检查出现不液化,下次检查又液化了,再来查又不液化了......?究竟什么是液化?什么导致不液化?精液不液化会不会导致男性不育?该如何处理?下文可解阁下之惑!一、精液的凝固和液化大有作用自然界的一切设计的都是如此精妙,精液凝固与液化便是很好的佐证。精液的凝固与液化为哺乳类动物所特有的自然生理现象;精液在排除体外后短时间内凝固尔后逐渐液化能

前列腺炎治疗指南

前列腺炎治疗指南.doc

又出事!妇女“前列腺炎”在卫生室输头孢死亡

据中华消费网消息,3月16日,湖北十堰市均县镇寨怀沟52岁的妇女曾国兰因“小便不适”在村卫生室被诊断为“前列腺炎”。